These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 24881814)
1. Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer. Schüler S; Lattrich C; Skrzypczak M; Fehm T; Ortmann O; Treeck O Gene; 2014 Aug; 546(2):283-7. PubMed ID: 24881814 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility. Treeck O; Elemenler E; Kriener C; Horn F; Springwald A; Hartmann A; Ortmann O J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):207-11. PubMed ID: 19429453 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the promoter region of estrogen receptor β gene in endometrial cancer. Lattrich C; Häring J; Schüler S; Skrzypczak M; Ortmann O; Treeck O Arch Gynecol Obstet; 2014 Mar; 289(3):631-5. PubMed ID: 23974281 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the epidemiological and prognosis significance of ESR2 rs3020450 polymorphism in ovarian cancer. Feng Y; Peng Z; Liu W; Yang Z; Shang J; Cui L; Duan F Gene; 2019 Aug; 710():316-323. PubMed ID: 31200086 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor beta polymorphism is associated with prostate cancer risk. Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880 [TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma. Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT Cancer Causes Control; 2009 Feb; 20(1):47-55. PubMed ID: 18704709 [TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States). Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I Cancer Causes Control; 2004 Aug; 15(6):627-33. PubMed ID: 15280642 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. Pirskanen M; Hiltunen M; Mannermaa A; Helisalmi S; Lehtovirta M; Hänninen T; Soininen H Eur J Hum Genet; 2005 Sep; 13(9):1000-6. PubMed ID: 15944651 [TBL] [Abstract][Full Text] [Related]
12. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese. Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404 [TBL] [Abstract][Full Text] [Related]
13. Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease. Goumidi L; Dahlman-Wright K; Tapia-Paez I; Matsson H; Pasquier F; Amouyel P; Kere J; Lambert JC; Meirhaeghe A J Alzheimers Dis; 2011; 26(3):431-9. PubMed ID: 21673408 [TBL] [Abstract][Full Text] [Related]
14. Significance of rs1271572 in the estrogen receptor beta gene promoter and its correlation with breast cancer in a southwestern Chinese population. Chen L; Liang Y; Qiu J; Zhang L; Chen X; Luo X; Jiang J J Biomed Sci; 2013 May; 20(1):32. PubMed ID: 23711151 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor polymorphisms and the risk of endometrial cancer. Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492 [TBL] [Abstract][Full Text] [Related]
16. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer]. Jin X; Kang S; Wang N; Xing YP; Li Y Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249 [TBL] [Abstract][Full Text] [Related]
18. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201 [TBL] [Abstract][Full Text] [Related]
19. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma]. Liang J; Li Y; Wang N Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242 [TBL] [Abstract][Full Text] [Related]
20. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer]. Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]